|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chalasani V, Chin JL and Izawa JI:
Histologic variants of urothelial bladder cancer and nonurothelial
histology in bladder cancer. Can Urol Assoc J. 3:(6 Suppl 4).
S193–S198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Antunes AA, Nesrallah LJ, Dall'Oglio MF,
Maluf CE, Camara C, Leite KR and Srougi M: The role of squamous
differentiation in patients with transitional cell carcinoma of the
bladder treated with radical cystectomy. Int Braz J Urol.
33:339–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang MH, Yen CC, Chen PM, Wang WS, Chang
YH, Huang WJ, Fan FS, Chiou TJ, Liu JH and Chen KK:
Prognostic-factors-based risk-stratification model for invasive
urothelial carcinoma of the urinary bladder in Taiwan. Urology.
59:232–239. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lopez-Beltran A, Requena MJ,
Alvarez-Kindelan J, Quintero A, Blanca A and Montironi R: Squamous
differentiation in primary urothelial carcinoma of the urinary
tract as seen by MAC387 immunohistochemistry. J Clin Pathol.
60:332–335. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Domanowska E, Jozwicki W, Domaniewski J,
Golda R, Skok Z, Wiśniewska H, Sujkowska R, Wolski Z and Jozwicka
G: Muscle-invasive urothelial cell carcinoma of the human bladder:
Multidirectional differentiation and ability to metastasize. Hum
Pathol. 38:741–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grace DA and Winter CC: Mixed
differentiation of primary carcinoma of the urinary bladder.
Cancer. 21:1239–1243. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fegen JP, Albert DJ and Persky L:
Adenocarcinoma and transitional cell carcinoma occurring
simultaneously in the urinary bladder (mixed tumor). J Surg Oncol.
3:387–392. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kastritis E, Dimopoulos MA, Antoniou N,
Deliveliotis C, Chrisofos M, Skolarikos A, Gika D and Bamias A: The
outcome of patients with advanced pure squamous or mixed squamous
and transitional urothelial carcinomas following platinum-based
chemotherapy. Anticancer Res. 26:3865–3869. 2006.PubMed/NCBI
|
|
10
|
Scosyrev E, Ely BW, Messing EM, Speights
VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL,
Natale RB, et al: Do mixed histological features affect survival
benefit from neoadjuvant platinum-based combination chemotherapy in
patients with locally advanced bladder cancer? A secondary analysis
of southwest oncology group-directed intergroup study (S8710). BJU
Int. 108:693–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SP, Frank I, Cheville JC, Thompson RH,
Weight CJ, Thapa P and Boorjian SA: The impact of squamous and
glandular differentiation on survival after radical cystectomy for
urothelial carcinoma. J Urol. 188:405–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Honma I, Masumori N, Sato E, Takayanagi A,
Takahashi A, Itoh N, Tamagawa M, Sato MA and Tsukamoto T: Local
recurrence after radical cystectomy for invasive bladder cancer: An
analysis of predictive factors. Urology. 64:744–748. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frazier HA, Robertson JE, Dodge RK and
Paulson DF: The value of pathologic factors in predicting
cancer-specific survival among patients treated with radical
cystectomy for transitional cell carcinoma of the bladder and
prostate. Cancer. 71:3993–4001. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jozwicki W, Domaniewski J, Skok Z, Wolski
Z, Domanowska E and Jozwicka G: Usefulness of histologic
homogeneity estimation of muscle-invasive urinary bladder cancer in
an individual prognosis: A mapping study. Urology. 66:1122–1126.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Billis A, Schenka AA, Ramos CC, Carneiro
LT and Araujo V: Squamous and/or glandular differentiation in
urothelial carcinoma: Prevalence and significance in transurethral
resections of the bladder. Int Urol Nephrol. 33:631–633. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mazzucchelli R, Morichetti D,
Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z and Montironi R:
Neuroendocrine tumours of the urinary system and male genital
organs: Clinical significance. BJU Int. 103:1464–1470. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours. Wiley-Liss; 2002
|
|
18
|
Mostofi FK, Sobin LH and Torlini H:
Histologic typing of urinary bladder tumours. World Health
Organization; Geneva: pp. 1–20. 1973
|
|
19
|
Coulson WF: Clinical importance of
squamous metaplasia in invasive transitional cell carcinoma of the
bladder. J Clin Pathol. 42:1227–1228. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Babjuk M, Burger M, Zigeuner R, Shariat
SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A,
Palou Redorta J, et al: EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder: Update 2013. Eur Urol.
64:639–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mazzucchelli L, Bacchi M, Studer UE,
Markwalder R, Sonntag RW and Kraft R: Invasion depth is the most
important prognostic factor for transitional-cell carcinoma in a
prospective trial of radical cystectomy and adjuvant chemotherapy.
Int J Cancer. 57:15–20. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shapur NK, Katz R, Pode D, Shapiro A,
Yutkin V, Pizov G, Appelbaum L, Zorn KC and Duvdevani M: Is radical
cystectomy mandatory in every patient with variant histology of
bladder cancer. Rare Tumors. 3:e222011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Erdemir F, Tunc M, Ozcan F, Parlaktas BS,
Uluocak N, Kilicaslan I and Gokce O: The effect of squamous and/or
glandular differentiation on recurrence, progression and survival
in urothelial carcinoma of bladder. Int Urol Nephrol. 39:803–807.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Logothetis CJ, Dexeus FH, Chong C, Sella
A, Ayala AG, Ro JY and Pilat S: Cisplatin, cyclophosphamide and
doxorubicin chemotherapy for unresectable urothelial tumors: The
M.D. Anderson experience. J Urol. 141:33–37. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miller JS and Epstein JI: Noninvasive
urothelial carcinoma of the bladder with glandular differentiation:
Report of 24 cases. Am J Surg Pathol. 33:1241–1248. 2009.
View Article : Google Scholar : PubMed/NCBI
|
